To assess the safety and tolerability of single agent RP1 in selected organ transplant recipients
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Replimune Group, INC
Start Date
February 24, 2021
End Date
September 30, 2025
Administered By
School of Medicine
Awarded By
Replimune Group, INC
Start Date
February 24, 2021
End Date
September 30, 2025